These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 36674402

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.
    Rivera AV, Nolan ML, Paone D, Carrillo SA, Braunstein SL.
    Subst Abus; 2022; 43(1):1172-1179. PubMed ID: 35617642
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fentanyl overdose concerns among people who inject drugs: The role of sex, racial minority status, and overdose prevention efforts.
    Jones AA, Schneider KE, Mahlobo CT, Maggs JL, Dayton L, Tobin KE, Latkin CA.
    Psychol Addict Behav; 2023 Mar; 37(2):191-198. PubMed ID: 35511529
    [Abstract] [Full Text] [Related]

  • 9. Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review.
    Luna G, Dermid G, Unger JB.
    Harm Reduct J; 2024 Aug 16; 21(1):150. PubMed ID: 39152433
    [Abstract] [Full Text] [Related]

  • 10. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
    Collins AB, Kaplowitz E, Bastani P, McKee H, Whitaker D, Hallowell BD, McKenzie M.
    Subst Use Misuse; 2024 Aug 16; 59(5):673-679. PubMed ID: 38124349
    [Abstract] [Full Text] [Related]

  • 11. Harm Reduction and Treatment Among People at High Risk of Overdose.
    Bandara S, Byrne L, Berman V, Hurst A, King D, Gibbons JB, Sugarman OK, Livingston A, Kerins L, Hulsey EG, Alves A, Saloner B.
    JAMA Netw Open; 2024 Aug 01; 7(8):e2427241. PubMed ID: 39133486
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont.
    Erath TG, LaCroix R, O'Keefe E, Higgins ST, Rawson RA.
    Harm Reduct J; 2024 Apr 05; 21(1):76. PubMed ID: 38580997
    [Abstract] [Full Text] [Related]

  • 16. Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting.
    Hayashi K, Wood E, Dong H, Buxton JA, Fairbairn N, DeBeck K, Milloy MJ, Kerr T.
    Drug Alcohol Rev; 2021 Sep 05; 40(6):964-973. PubMed ID: 33604968
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply.
    Bell A, Bennett AS, Jones TS, Doe-Simkins M, Williams LD.
    Subst Abus; 2019 Sep 05; 40(1):52-55. PubMed ID: 29558283
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
    Wilson M, Brumwell A, Stowe MJ, Shelly S, Scheibe A.
    Harm Reduct J; 2022 Feb 11; 19(1):17. PubMed ID: 35148779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.